Position in SVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$2,353,078 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Derivatives in SVRA
reported options exposure · as of Jun 30, 2026CallValue
$244,552
CallShares
39,700
PutValue
$80,696
PutShares
13,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in SVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,696 | 13,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $244,552 | 39,700 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $115,752 | 21,200 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $2,353,078 | 430,967 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $521,976 | 95,600 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $3,523,261 | 584,289 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $97,083 | 16,100 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $83,214 | 13,800 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $2,161,865 | 605,565 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $107,591 | 35,046 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $275,255 | 64,919 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $356,920 | 88,566 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $427,526 | 85,849 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $284,151 | 60,458 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $284,878 | 89,164 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $550,572 | 282,345 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $32,173 | 20,757 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $26,367 | 17,011 | Shares | Defined | 2022-11-15 | |
| 2021-06-30 | $35,409 | 20,829 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $15,637 | 14,346 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $42,857 | 17,212 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||